Amgen’s Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC


Posted in: Medical Condition News | Pharmaceutical News

Tags: Anorexia, Antibodies, Biotechnology, Cancer, Cell, Cell Culture, Cetuximab, Chemotherapy, Colorectal Cancer, Dehydration, Dermatitis, Diarrhea, Exon, Fatigue, Fibrosis, Genetics, Healthcare, Hypocalcemia, Hypokalemia, Irinotecan, Lung Cancer, Lung Disease, Managed Care, Nausea, Oxaliplatin, Pruritus, Pulmonary Fibrosis, Renal Failure, Sepsis, Stomatitis, Vectibix